# Gastrointestinal bleeding localisation

Source: https://nuclide.cc/indications/gastrointestinal-bleeding/  
Nuclide record `gastrointestinal-bleeding` (Indication). Data CC BY-NC 4.0, attribute "Data from Nuclide (nuclide.cc)"; commercial use needs a licence.

## TL;DR

When bleeding inside the gut is hard to pin down, labelling a patient's own red blood cells with a radioactive tracer and watching where blood leaks into the bowel over several hours can find the source, even if the bleeding comes and goes.

## Summary

Gastrointestinal bleeding scintigraphy (GIBS) detects and localises active bleeding into the bowel lumen using the patient's own red blood cells labelled with Tc-99m, exploiting the tracer's long intravascular half-life to allow continuous imaging of the entire gastrointestinal tract for many hours, unlike single-timepoint techniques such as CT angiography. It is used for both overt bleeding (melena, haematochezia) and, less often, occult bleeding, and is particularly valuable because gastrointestinal bleeding is frequently intermittent, so a technique that can watch continuously for extended periods has a real advantage over a snapshot study.

The SNMMI/ACNM (and previously SNMMI/EANM) procedure standard specifies an administered activity of 555-1,110 MBq of Tc-99m-labelled red blood cells (labelled in vitro, in vivo, or by a modified in vivo technique), dynamic imaging beginning immediately after injection at no more than one frame per 60 seconds, and a minimum of 60 minutes of initial imaging if no bleeding is seen, extendable up to 24 hours by rescanning if there is ongoing clinical suspicion. The diagnostic criteria require all three of: focal activity appearing outside expected blood-pool structures, a change in the intensity of that activity between images, and a pattern of movement consistent with peristalsis through the bowel - meeting only one or two of these criteria is not sufficient to call a positive study.

Because the test can detect bleeding rates as low as roughly 0.1 mL per minute in clinical use, it is generally more sensitive than catheter angiography (which typically needs faster bleeding, around 0.5-1 mL/min, to show extravasation) and is often used to decide whether, and where, to proceed to angiography and embolisation or, alternatively, direct the endoscopist or surgeon to the likely segment of bowel. It requires no patient preparation, has minimal radiation burden relative to repeated CT, and can be safely performed in haemodynamically unstable patients provided appropriate monitoring is in place.

## Fields

- Kind: Indication
- Last checked: 2026-09-22
- Tags: gastroenterology; dynamic imaging; emergency
- Group: gastroenterology
- Burden: Gastrointestinal bleeding is a common reason for hospital admission; lower gastrointestinal bleeding alone accounts for a large share of gastroenterology-related emergency presentations, and GIBS is one of the most frequently requested non-oncological nuclear medicine studies performed on an urgent basis.

## Standard of care

- Suspected active overt gastrointestinal bleeding, source unclear on endoscopy or unstable for endoscopy: Tc-99m-labelled red blood cell scintigraphy, imaged dynamically for a minimum of 60 minutes and extendable to 24 hours, read as positive only when focal extravascular activity changes in intensity and moves in a bowel pattern.
- Positive scintigraphy, further localisation or treatment needed: Catheter angiography with embolisation, or surgery, targeted to the segment identified on scintigraphy.

## State of the art

- The SNMMI Procedure Standard/ACNM Practice Guideline for Gastrointestinal Bleeding Scintigraphy 3.0 (2025) is the current version, building on the 2014 SNMMI/EANM standard, and formalises the three-part positivity criteria and updated paediatric weight-based dosing.
- Tc-99m-RBC scintigraphy remains more sensitive for intermittent, low-rate bleeding than CT angiography or catheter angiography, which need a higher active bleeding rate to show extravasation at the single moment of image acquisition.

## Open problems

- Serial intermittent static imaging is explicitly discouraged in favour of continuous dynamic acquisition, but adherence to this varies across centres with older equipment or workflow constraints.
- The scan localises bleeding to a general bowel region rather than a precise anatomical point, so it complements rather than replaces endoscopy or angiography for definitive treatment planning.
- In vivo versus in vitro red blood cell labelling technique affects labelling efficiency and image quality; the highest-efficiency in vitro kit-based labelling is not universally available.

## Sources

- The SNMMI Procedure Standard/EANM Practice Guideline for gastrointestinal bleeding scintigraphy 2.0: https://tech.snmjournals.org/content/42/4/308
- The SNMMI Procedure Standard/ACNM Practice Guideline for Gastrointestinal Bleeding Scintigraphy 3.0 (2025): https://tech.snmjournals.org/content/53/1/14

## Connected records

- isotopes: [Technetium-99m](https://nuclide.cc/isotopes/tc-99m/)
- technologies: [SPECT & bone scan](https://nuclide.cc/technologies/spect/)

---
JSON: https://nuclide.cc/api/v1/entities/gastrointestinal-bleeding.json